Ashley Morales is an associate in our San Diego office. Her practice focuses on litigation. She represents clients in a wide variety of intellectual property disputes, including pharmaceutical cases in the Hatch-Waxman context. Her cases have involved a range of technologies, including mechanical and medical devices.
Ashley is experienced in due diligence and opinion work in the biotech, chemical, and pharmaceutical fields, and assists in patent prosecution in the chemical and pharmaceutical fields.
Ashley received her law degree from Columbia Law School, where she was Executive Editor for the Columbia Journal of Environmental Law. She received her bachelor's degree in chemistry and political science from the University of Southern California.
Ashley joined the firm in 2015.
Co-authored, Hatch-Waxman And Copying: An Exception To The Exception?, Law360 (November 2017)
Co-authored, Evidence Of Copying Is Irrelevant In Hatch-Waxman Cases, Law360 (September 2016)
Potential Claim Construction Error Is Harmless When Not Relied Upon by the Board
Patent Term Adjustment Under 35 U.S.C. 154(b)(1)(C)(iii) Requires Reversal of Adverse Determination of Patentability
- Required Testing as Part of an Offer for Sale Does Not Preclude a Finding of a Commercial Sale for On-Sale Bar Defense
- Prosecution History Disclaimer and Estoppel Lead To Noninfringement
- Registration of a Multi-Color Mark Does Not Require Acquired Distinctiveness
- Single-Entity Requirement for Infringement Under § 271(a) Does Not Apply to § 271(g)